Updated WHO 6-Month MDR-TB Regimen resisttbMay 5, 20221 min readAttached below is the updated WHO guidelines which contains a revision of the 6-Month MDR-TB regimen for adults.WHO-UCN-TB-2022.2-eng.pdfDownload PDF • 196KB
Open letter: Experts call for urgent expansion of Pretomanid labelDespite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...
WHO Accelerator Platform for Novel TB Regimens The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...
WHO announces landmark changes in treatment of drug-resistant tuberculosisThe WHO released comprehensive guidelines for TB this week and shared important new updates to treatment options for MDR-TB. In...
Comments